- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00030095 | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00042861 |
| UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors |
| completed |
| Phase 1 |
| — |
| National Cancer Institute (NCI)NIH |
| 1 |
| Apr 30, 2015 |
| clinicaltrials |
| NCT00045500 | UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00072111 | Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00003993 | Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 24 | National Institute on Aging (NIA)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019344 | Flavopiridol in Treating Patients With Refractory Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019357 | Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019656 | Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00217373 | Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2015 | clinicaltrials |
| NCT00255658 | Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00049400 | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction | completed | Phase 1 | 78 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 3, 2015 | clinicaltrials |
| NCT00352443 | S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | 66 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 6, 2015 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01218620 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00217477 | Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 34 | Roswell Park Cancer InstituteOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT00276575 | Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 65 | Herbert Hurwitz, MDOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT01245205 | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2014 | clinicaltrials |
| NCT00004258 | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | 40 | Indiana UniversityOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00057915 | Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer | completed | Phase 1 | 4 | Duke UniversityOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00275080 | Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Aug 27, 2014 | clinicaltrials |
| NCT00567931 | 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT01191216 | 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00058253 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00121264 | 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT01198184 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00415324 | Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00002923 | KRN5500 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00028548 | XK469 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00004144 | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | completed | Phase 1 | 31 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 11, 2014 | clinicaltrials |
| NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01096355 | Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01243359 | Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | completed | Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00890747 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2014 | clinicaltrials |
| NCT00003766 | O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery | completed | Phase 1 | 25 | University of ChicagoOTHER | 1 | Mar 6, 2014 | clinicaltrials |
| NCT00046917 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00121290 | SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00227513 | Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00324480 | Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00348699 | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00357318 | Bevacizumab and Sunitinib in Treating Patients With Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00462553 | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00499811 | Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01145456 | Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00458731 | Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma | completed | Phase 1 | 57 | National Cancer Institute (NCI)NIH | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00054288 | Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Apr 30, 2015source: clinicaltrials